ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

miR-101 sensitizes K562 cell line to imatinib through Jak2 downregulation and inhibition of NF-κB target genes.

Elham Farhadi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.